Cargando…

The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2−/+ Breast Cancer

BACKGROUND: Previous findings indicated that polymorphism in gene catechol-O-methyltransferase (COMT) had been linked to chemotherapy-related cognitive impairment (CRCI). Nevertheless, the motivation of COMT polymorphisms in regulating cognitive impairment in breast cancer survivors with disparate s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wen, Zhang, Qianqian, Cai, Yinlian, Chen, Tingting, Cheng, Huaidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861381/ https://www.ncbi.nlm.nih.gov/pubmed/35211407 http://dx.doi.org/10.3389/fonc.2022.816923

Ejemplares similares

Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting‐state fMRI
por: Yao, Senbang, et al.
Publicado: (2023)

Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy‐related cognitive impairment in patients with breast cancer who receive chemotherapy
por: Yao, Senbang, et al.
Publicado: (2022)

Altered resting-state hippocampal functional networks associated with chemotherapy-induced prospective memory impairment in breast cancer survivors
por: Cheng, Huaidong, et al.
Publicado: (2017)

Chemotherapy-induced prospective memory impairment in breast cancer patients with different hormone receptor expression
por: Li, Wen, et al.
Publicado: (2017)

Depression involved in self-reported prospective memory problems in survivors of breast cancer who have received chemotherapy
por: Huang, Zhonglian, et al.
Publicado: (2019)

Identification of hub genes related to CD4(+) memory T cell infiltration with gene co-expression network predicts prognosis and immunotherapy effect in colon adenocarcinoma
por: Tang, Lingxue, et al.
Publicado: (2022)

Immunotherapy for HER-2 positive breast cancer
por: Yang, Tingting, et al.
Publicado: (2023)

Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors
por: Ding, Ke, et al.
Publicado: (2020)

Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression
por: Li, Wen, et al.
Publicado: (2020)

Efficacy and Safety of Anti-HER2 Agents in Combination With Chemotherapy for Metastatic HER2-Positive Breast Cancer Patient: A Network Meta-Analysis
por: Zhang, Xiaohui, et al.
Publicado: (2021)

Re: Response to In regard to Ding et al. 2020: “Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy Related Cognitive Impairment in Breast Cancer Survivors”
por: Cheng, Huaidong, et al.
Publicado: (2023)

Therapy-Related Acute Myeloid Leukemia Following TCHP Chemotherapy in Two HER2+ Breast Cancer Patients
por: Gill, Navroop, et al.
Publicado: (2020)

Efficacy and Safety of Albumin-Bound Paclitaxel Compared to Docetaxel as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer
por: Lv, Zhi-Dong, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis
por: Ibrahim, Eiman Y., et al.
Publicado: (2021)

Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis
por: Debiasi, Márcio, et al.
Publicado: (2018)

RecurIndex assay as an aid for adjuvant chemotherapy decisions in HR-positive HER2-negative breast cancer patients
por: Wang, Haibo, et al.
Publicado: (2022)

Human clinical trial using diagnostic ultrasound and microbubbles to enhance neoadjuvant chemotherapy in HER2- negative breast cancer
por: Zhou, Biqiang, et al.
Publicado: (2022)

PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancer
por: Ozcan, Gulnihal
Publicado: (2023)

The Anti-Inflammatory Drug Aspirin Does Not Protect Against Chemotherapy-Induced Memory Impairment by Paclitaxel in Mice
por: Chang, Aeson, et al.
Publicado: (2020)

COMT and ANKK1-Taq-Ia Genetic Polymorphisms Influence Visual Working Memory
por: Berryhill, Marian E., et al.
Publicado: (2013)

The alterations in event-related potential responses to pain empathy in breast cancer survivors treated with chemotherapy
por: Li, Wen, et al.
Publicado: (2022)

The Role of Chemotherapy in Patients With HER2-Negative Isolated Locoregional Recurrence of Breast Cancer: A Multicenter Retrospective Cohort Study
por: Lee, Kyoungmin, et al.
Publicado: (2021)

Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective study
por: Tang, Lingfeng, et al.
Publicado: (2022)

The anti-tumor efficiency of low-dose apatinib-based chemotherapy in pretreated HER2-negative breast cancer with brain metastases
por: Chen, Xuelian, et al.
Publicado: (2023)

A Pilot Study of Cardiac MRI in Breast Cancer Survivors After Cardiotoxic Chemotherapy and Three-Dimensional Conformal Radiotherapy
por: Bergom, Carmen, et al.
Publicado: (2020)

Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers
por: Chow, Christopher Y.C., et al.
Publicado: (2022)

Comte
por: Marvin, Francis Sydney, 1863-1943
Publicado: (1941)

Life after breast cancer: moving on, sitting down or standing still? A prospective study of Canadian breast cancer survivors
por: Sabiston, Catherine M, et al.
Publicado: (2018)

Pyrotinib in the Treatment of Women With HER2-Positive Advanced Breast Cancer: A Multicenter, Prospective, Real-World Study
por: Zhang, Lili, et al.
Publicado: (2021)

Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
por: Li, Yi, et al.
Publicado: (2020)

ERCC1 is a potential biomarker for predicting prognosis, immunotherapy, chemotherapy efficacy, and expression validation in HER2 over-expressing breast cancer
por: Li, Yilun, et al.
Publicado: (2022)

Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study
por: Fabbri, Agnese, et al.
Publicado: (2023)

Effects of high-intensity interval training on vascular function in breast cancer survivors undergoing anthracycline chemotherapy: design of a pilot study
por: Lee, Kyuwan, et al.
Publicado: (2018)

Vestibulotoxicity Associated With Platinum-Based Chemotherapy in Survivors of Cancer: A Scoping Review
por: Prayuenyong, Pattarawadee, et al.
Publicado: (2018)

The role of radiotherapy in HER2+ early-stage breast cancer patients after breast-conserving surgery
por: Yang, Huanzuo, et al.
Publicado: (2023)

Effects of COMT Genotypes on Working Memory Performance in Fibromyalgia Patients
por: Ferrera, David, et al.
Publicado: (2020)

A Meta-Analysis of Cognitive Impairment and Decline Associated with Adjuvant Chemotherapy in Women with Breast Cancer
por: Ono, Miyuki, et al.
Publicado: (2015)

Association of genetic ancestry with HER2, GRB7 AND estrogen receptor expression among Colombian women with breast cancer
por: Rey-Vargas, Laura, et al.
Publicado: (2022)

Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients
por: Li, Wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f8r0armt50iuomdtt0asqkiam0